MIRA Pharmaceuticals, Inc. (MIRA) Stock Statistics & Valuation Metrics

MIRA Pharmaceuticals, Inc. has a market cap or net worth of $66.58M. The enterprise value is ―.

MIRA Pharmaceuticals, Inc. has 41,876,087 shares outstanding. The number of shares has decreased by -2.65% in one year.

MIRA Pharmaceuticals, Inc.’s return on equity (ROE) is -3.57 and return on invested capital (ROIC) is -364.51%.

The current PE Ratio of MIRA Pharmaceuticals, Inc. is ―. MIRA Pharmaceuticals, Inc.’s PEG ratio is 0.10.

In the last 12 months, MIRA Pharmaceuticals, Inc. had revenue of 0.00 and earned -7.85M in profits. Earnings per share was -0.51.

In the last 12 months, operating cash flow was -5.33M and capital expenditures 1.00, giving a free cash flow of -5.33M billion.

MIRA Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

MIRA Pharmaceuticals, Inc. upcoming earnings date is ―, ―.

MIRA Pharmaceuticals, Inc. as a current ratio of 3.99, with Debt / Equity ratio of 0.00%

In the past 12 months, MIRA Pharmaceuticals, Inc. has paid 0.00 in taxes.

MIRA Pharmaceuticals, Inc. EV to EBITDA ratio is -1.88, with an EV/FCF ratio of -2.66.

MIRA Pharmaceuticals, Inc. has $2.64M in cash and marketable securities with $0.00 in debt, giving a net cash position of $2.64M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for MIRA Pharmaceuticals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―